These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1747973)

  • 21. Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?
    Figueredo VM; Amidon TM; Wolfe CL
    Postgrad Med; 1994 Dec; 96(8):30-4, 37-40. PubMed ID: 7991476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic therapy in acute MI. Weighing the risks and benefits.
    Ro KG; Anderson HV
    Postgrad Med; 1990 Dec; 88(8):79-80, 83-6, 89-90 passim. PubMed ID: 2123035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. After ISIS-3.
    Hannaford PC; Kay CR
    Lancet; 1992 May; 339(8803):1225; author reply 1226-7. PubMed ID: 1349950
    [No Abstract]   [Full Text] [Related]  

  • 24. Is thrombolytic therapy safe during active menstruation?
    Sekyema YF; Baltazar RF
    J Emerg Med; 1995; 13(3):345-8. PubMed ID: 7673627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early patency in acute myocardial infarction.
    Belenkie I
    Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiographic studies demonstrating the need for conjunctive anticoagulation.
    Bleich SD
    Coron Artery Dis; 1996 Jul; 7(7):516-21. PubMed ID: 8913669
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of thrombolytic therapy on hemoglobin change after acute myocardial infarction.
    Tahnk-Johnson ME; Sharkey SW
    Am J Cardiol; 1993 Apr; 71(10):869-72. PubMed ID: 8456772
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemorrhagic aspects of thrombolytic therapy.
    Samama M
    Eur Heart J; 1990 Aug; 11 Suppl F():15-8. PubMed ID: 2121488
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombolytic therapy after cardiopulmonary resuscitation in acute myocardial infarction.
    Neches RB; Goldfarb AM
    Am J Cardiol; 1993 Jan; 71(2):258. PubMed ID: 8421997
    [No Abstract]   [Full Text] [Related]  

  • 32. Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction.
    Barbash GI; Hod H; Rath S; Miller HI; Roth A; Har-Zahav Y; Modan M; Rotstein Z; Batler A; Zivelin A
    Am J Cardiol; 1989 Jul; 64(3):225-8. PubMed ID: 2500841
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronary thrombolysis: round two and beyond.
    Wilcox RG
    Br Heart J; 1991 Apr; 65(4):175-6. PubMed ID: 1903042
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
    N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of ISIS-3 reported at ACC annual meeting.
    Can J Cardiol; 1991 Apr; 7(3):VI-VII. PubMed ID: 1904302
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombolysis following pre-hospital cardiopulmonary resuscitation.
    Weston CF; Avery P
    Int J Cardiol; 1992 Nov; 37(2):195-8. PubMed ID: 1452376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive medications in patients receiving thrombolytic therapy: a multicenter prospective assessment. The Virginia Multicenter Thrombolytic Study Group.
    Gonzalez ER; Jones LA; Ornato JP; Bleecker GC; Strauss MJ
    Ann Pharmacother; 1992 Nov; 26(11):1383-4. PubMed ID: 1362094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver rupture after cardiopulmonary resuscitation in a patient receiving thrombolytic therapy.
    Druwé PM; Cools FJ; De Raedt HJ; Bossaert LL
    Resuscitation; 1996 Oct; 32(3):213-6. PubMed ID: 8923584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Chelluri L; Sirio CA; Angus DC
    N Engl J Med; 1994 Feb; 330(7):505; author reply 505-6. PubMed ID: 8289862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.